Literature DB >> 16770531

Structure function relationships in the lymphatic system and implications for cancer biology.

Marlys H Witte1, Kimberly Jones, Jörg Wilting, Michael Dictor, Manuel Selg, Noel McHale, Jeffrey E Gershenwald, David G Jackson.   

Abstract

The lymphatic system, composed of lymphatic vessels, lymph, lymph nodes, and lymphocytes, is a distinctive vasculature (discontinuous basement membrane, open endothelial junctions, anchoring filaments, valves, and intrinsic contractility), different yet similar to the blood vasculature; an integral component of the plasma-tissue fluid-lymph circulation (the "blood-lymph loop"); and the center of the immunoregulatory network. Lymphatics are involved in diverse developmental, growth, repair, and pathologic processes both analogous to and distinct from those affecting the blood vasculature. Interference with the blood-lymph loop produces swelling [an imbalance between lymph formation (regulated by Starling's law of transcapillary fluid exchange) and lymph absorption], scarring, nutritional and immunodysregulatory disorders, as well as disturbances in lymph(hem)angiogenesis (lymphedema-angiodysplasia syndromes). The lymphatic system is also the stage on which key events during cancer development and progression are played out, and historically, also forms the basis for current evaluation, prognostication, and/or both operative and non-operative treatment of most cancers. Recent advances in molecular lymphology (e.g., discovery of lymphatic growth factors, endothelial receptors, transcription factors, genes, and highly specific immunohistochemical markers) and growing interest in lymphangiogenesis, combined with fresh insights and refined tools in clinical lymphology, including non-invasive lymphatic imaging, are opening up a window for translation to the clinical arena. Therefore, in cancer biology, attention to the multifaceted structure-function relationships within this vast, relatively unexplored system is long overdue.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16770531     DOI: 10.1007/s10555-006-8496-2

Source DB:  PubMed          Journal:  Cancer Metastasis Rev        ISSN: 0167-7659            Impact factor:   9.264


  31 in total

Review 1.  Advances in small animal mesentery models for in vivo flow cytometry, dynamic microscopy, and drug screening.

Authors:  Ekaterina I Galanzha; Valery V Tuchin; Vladimir P Zharov
Journal:  World J Gastroenterol       Date:  2007-01-14       Impact factor: 5.742

2.  Plasticity of button-like junctions in the endothelium of airway lymphatics in development and inflammation.

Authors:  Li-Chin Yao; Peter Baluk; R Sathish Srinivasan; Guillermo Oliver; Donald M McDonald
Journal:  Am J Pathol       Date:  2012-04-23       Impact factor: 4.307

3.  Can lymphatic vascular density be used in determining metastatic spreading potential of tumor in invasive ductal carcinomas?

Authors:  Nilufer Onak Kandemir; Figen Barut; Sibel Bektas; Sukru Oguz Ozdamar
Journal:  Pathol Oncol Res       Date:  2011-07-23       Impact factor: 3.201

4.  Isolation of human lymphatic endothelial cells by multi-parameter fluorescence-activated cell sorting.

Authors:  Zerina Lokmic; Elizabeth S Ng; Matthew Burton; Edouard G Stanley; Anthony J Penington; Andrew G Elefanty
Journal:  J Vis Exp       Date:  2015-05-01       Impact factor: 1.355

Review 5.  Translational/personalized medicine, pharmaco/surgico/radiogenomics, lymphatic spread of cancer, and medical ignoromes.

Authors:  Marlys H Witte
Journal:  J Surg Oncol       Date:  2011-05-01       Impact factor: 3.454

Review 6.  Lymphangiogenesis and hemangiogenesis: potential targets for therapy.

Authors:  Marlys H Witte; Michael T Dellinger; Donald M McDonald; S David Nathanson; Francesco M Boccardo; Corradino C C Campisi; Jonathan P Sleeman; Jeffrey E Gershenwald
Journal:  J Surg Oncol       Date:  2011-05-01       Impact factor: 3.454

7.  TNF-derived peptides inhibit tumour growth and metastasis through cytolytic effects on tumour lymphatics.

Authors:  W Lu; Y Wang; Q Zhang; S Owen; M Green; T Ni; M Edwards; Y Li; L Zhang; A Harris; J-L Li; D G Jackson; S Jiang
Journal:  Clin Exp Immunol       Date:  2019-07-03       Impact factor: 4.330

8.  alpha5beta1 Integrin blockade inhibits lymphangiogenesis in airway inflammation.

Authors:  Tatsuma Okazaki; Amy Ni; Oluwasheyi A Ayeni; Peter Baluk; Li-Chin Yao; Doerte Vossmeyer; Gunther Zischinsky; Grit Zahn; Jochen Knolle; Claudia Christner; Donald M McDonald
Journal:  Am J Pathol       Date:  2009-05-14       Impact factor: 4.307

9.  High density of peritumoral lymphatic vessels is a potential prognostic marker of endometrial carcinoma: a clinical immunohistochemical method study.

Authors:  Ying Gao; Zi Liu; Fei Gao; Xiao-yu Meng
Journal:  BMC Cancer       Date:  2010-04-08       Impact factor: 4.430

10.  Fluorescence in situ hybridization markers for prediction of cervical lymph node metastases.

Authors:  Darawalee Wangsa; Kerstin Heselmeyer-Haddad; Patricia Ried; Elina Eriksson; Alejandro A Schäffer; Larry E Morrison; Juhua Luo; Gert Auer; Eva Munck-Wikland; Thomas Ried; Elisabeth Avall Lundqvist
Journal:  Am J Pathol       Date:  2009-11-05       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.